Paratek Pharma Inc
(PRTK)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Sales | 9,597 | 19,694 | 12,500 | 5,208 | 0 |
| Gross Profit | 9,597 | 19,694 | 12,500 | 5,208 | N/A |
| Operating Expenses | 21,454 | 23,458 | 21,722 | 27,279 | 20,272 |
| Operating Income | -11,857 | -3,764 | -9,222 | -22,071 | -20,272 |
| Interest Expense | 159 | 116 | 0 | 179 | 766 |
| Other Income | 0 | 0 | -81 | 450 | 1,079 |
| Pre-tax Income | -12,016 | -3,880 | -9,303 | -21,800 | -19,959 |
| Net Income Continuous | -12,016 | -3,880 | -9,303 | -21,800 | -19,959 |
| Net Income | $-12,016 | $-3,880 | $-9,303 | $-21,800 | $-19,959 |
| EPS Basic Total Ops | -8.40 | -3.48 | -8.28 | -21.49 | -597.48 |
| EPS Basic Continuous Ops | -8.46 | -3.44 | -8.32 | -21.51 | -597.52 |
| EPS Diluted Total Ops | -8.40 | -3.48 | -8.28 | -21.49 | -597.48 |
| EPS Diluted Continuous Ops | -8.46 | -3.44 | -8.32 | -21.51 | -597.52 |
| EBITDA(a) | $-11,258 | $-2,473 | $-7,701 | $-20,332 | $-20,065 |